TERM ID="NYU_TERM_1" STRING="AF" FREQUENCY=3 START=115 END=117 LEMMA="ATRIAL FIBRILLATION" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_2" STRING="AF" FREQUENCY=3 START=371 END=373 LEMMA="ATRIAL FIBRILLATION" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_3" STRING="AF" FREQUENCY=3 START=664 END=666 LEMMA="ATRIAL FIBRILLATION" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_4" STRING="Atrial fibrillation" FREQUENCY=1 START=94 END=113 LEMMA="ATRIAL FIBRILLATION" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_5" STRING="CHADS2" FREQUENCY=1 START=412 END=418 LEMMA="CHADS2" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="CHADS2 score" FREQUENCY=2 START=604 END=616 LEMMA="CHADS2 SCORE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_7" STRING="CHADS2 score" FREQUENCY=2 START=809 END=821 LEMMA="CHADS2 SCORE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_8" STRING="INR range" FREQUENCY=1 START=257 END=266 LEMMA="INR RANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="OAT" FREQUENCY=1 START=237 END=240 LEMMA="ORAL ANTICOAGULANT THERAPY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_10" STRING="Oral anticoagulant therapy" FREQUENCY=2 START=209 END=235 LEMMA="ORAL ANTICOAGULANT THERAPY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_11" STRING="Oral anticoagulant therapy" FREQUENCY=2 START=209 END=235 LEMMA="ORAL ANTICOAGULANT THERAPY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_12" STRING="Risk stratification" FREQUENCY=1 START=0 END=19 LEMMA="RISK STRATIFICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="Risk stratification for thromboembolism" FREQUENCY=1 START=0 END=39 LEMMA="THROMBOEMBOLISM RISK STRATIFICATION" LEMMA_FREQUENCY=1 HEAD_TERM="Risk stratification" HEAD_LEMMA="RISK STRATIFICATION"
TERM ID="NYU_TERM_14" STRING="anticoagulation" FREQUENCY=1 START=895 END=910 LEMMA="ANTICOAGULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="antithrombotic prophylaxis" FREQUENCY=1 START=44 END=70 LEMMA="ANTITHROMBOTIC PROPHYLAXIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="apixaban" FREQUENCY=1 START=1152 END=1160 LEMMA="APIXABAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="atrial fibrillation Atrial fibrillation" FREQUENCY=1 START=74 END=113 LEMMA="ATRIAL FIBRILLATION ATRIAL FIBRILLATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="clinical practice underuse" FREQUENCY=1 START=838 END=864 LEMMA="CLINICAL PRACTICE UNDERUSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="discontinuations" FREQUENCY=1 START=925 END=941 LEMMA="DISCONTINUATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="factor Xa inhibitors" FREQUENCY=1 START=1115 END=1135 LEMMA="FACTOR XA INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="factor Xa inhibitors rivaroxaban" FREQUENCY=1 START=1115 END=1147 LEMMA="RIVAROXABAN FACTOR XA INHIBITOR" LEMMA_FREQUENCY=1 HEAD_TERM="rivaroxaban" HEAD_LEMMA="RIVAROXABAN"
TERM ID="NYU_TERM_22" STRING="intermediate-low" FREQUENCY=1 START=542 END=558 LEMMA="INTERMEDIATE-LOW" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="intermediate-low thromboembolic risk" FREQUENCY=1 START=542 END=578 LEMMA="THROMBOEMBOLIC RISK INTERMEDIATE-LOW" LEMMA_FREQUENCY=1 HEAD_TERM="thromboembolic risk" HEAD_LEMMA="THROMBOEMBOLIC RISK"
TERM ID="NYU_TERM_24" STRING="non-inferior" FREQUENCY=1 START=1181 END=1193 LEMMA="NON-INFERIOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="oral anticoagulants" FREQUENCY=1 START=1021 END=1040 LEMMA="ORAL ANTICOAGULANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="rivaroxaban" FREQUENCY=1 START=1136 END=1147 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="suboptimal quality" FREQUENCY=1 START=873 END=891 LEMMA="SUBOPTIMAL QUALITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="suboptimal quality of anticoagulation" FREQUENCY=1 START=873 END=910 LEMMA="ANTICOAGULATION SUBOPTIMAL QUALITY" LEMMA_FREQUENCY=1 HEAD_TERM="suboptimal quality" HEAD_LEMMA="SUBOPTIMAL QUALITY"
TERM ID="NYU_TERM_29" STRING="systemic embolism" FREQUENCY=1 START=178 END=195 LEMMA="SYSTEMIC EMBOLISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="therapeutic alternative" FREQUENCY=1 START=1243 END=1266 LEMMA="THERAPEUTIC ALTERNATIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="thrombin inhibitor dabigatran etexilate" FREQUENCY=1 START=1067 END=1106 LEMMA="THROMBIN INHIBITOR DABIGATRAN ETEXILATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="thromboembolic risk" FREQUENCY=3 START=298 END=317 LEMMA="THROMBOEMBOLIC RISK" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_33" STRING="thromboembolic risk" FREQUENCY=3 START=475 END=494 LEMMA="THROMBOEMBOLIC RISK" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_34" STRING="thromboembolic risk" FREQUENCY=3 START=559 END=578 LEMMA="THROMBOEMBOLIC RISK" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_35" STRING="thromboembolism" FREQUENCY=1 START=24 END=39 LEMMA="THROMBOEMBOLISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="warfarin" FREQUENCY=2 START=247 END=255 LEMMA="WARFARIN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_37" STRING="warfarin" FREQUENCY=2 START=1278 END=1286 LEMMA="WARFARIN" LEMMA_FREQUENCY=2
